Recombinant Human Vanin-1/VNN1 Protein, CF

R&D Systems | Catalog # 7999-AH

R&D Systems
Loading...

Key Product Details

  • R&D Systems CHO-derived Recombinant Human Vanin-1/VNN1 Protein (7999-AH)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

CHO

Accession Number

Applications

Enzyme Activity
Loading...

Product Specifications

Source

Chinese Hamster Ovary cell line, CHO-derived human Vanin-1/VNN1 protein
Gln22-Ser490, with a C-terminal 6-His tag

Purity

>95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain at 5 μg per lane.

Endotoxin Level

<0.01 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

No results obtained: Gln22 predicted

Predicted Molecular Mass

53 kDa

SDS-PAGE

60-80 kDa, reducing conditions

Activity

Measured by its ability to hydrolyze pantetheine to pantothenate and cysteamine.
The specific activity is >1500 pmol/min/μg, as measured under the described conditions.

Formulation, Preparation, and Storage

7999-AH
Formulation Supplied as a 0.2 μm filtered solution in HEPES, NaCl, DTT and Glycerol.
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -70 °C as supplied.
  • 3 months, -70 °C under sterile conditions after opening.

Background: Vanin-1/VNN1

Vanin‑1 (VNN1) is a member of the biotinidase family and is expressed at the cell surface in epithelial cells (1). VNN1 is also known as vascular non‑inflammatory molecule 1. It does not possess biotinidase activity, but is a pantetheinase that catalyzes the hydrolysis of pantetheine to pantothenic acid (vitamin‑B5) and cysteamine (2, 3). VNN1 is considered to be a potential biomarker for the acute kidney injury (4) and a target for therapeutic intervention in inflammatory bowel disease (5). Recombinant human VNN1 was engineered to have a C‑terminal truncation that prevents the normal GPI-anchor modification, resulting in its secretion.

References

  1. Pitari, G. et al. (2000) FEBS Lett. 483:149.
  2. Maras, B. et al. (1999) FEBS Lett. 461:149.
  3. Martin, F. et al. (2001) Immunogenetics 53:296.
  4. Hosohata, K. et al. (2012) J. Phamacol. Exp. Ther. 341:656.
  5. Berruyer, C. et al. (2006) J. Exp. Med. 203:2817.

Alternate Names

HDLCQ8, Pantetheinase, Pantetheine hydrolase, Tiff66, Vanin1, VNN1

Entrez Gene IDs

8876 (Human); 22361 (Mouse); 29142 (Rat)

Gene Symbol

VNN1

UniProt

Additional Vanin-1/VNN1 Products

Product Documents for Recombinant Human Vanin-1/VNN1 Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human Vanin-1/VNN1 Protein, CF

For research use only

Related Research Areas

Customer Reviews for Recombinant Human Vanin-1/VNN1 Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human Vanin-1/VNN1 Protein, CF and earn rewards!

Have you used Recombinant Human Vanin-1/VNN1 Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Human Vanin-1/VNN1 Protein, CF (7999-AH):

Materials
  • Assay Buffer: 50 mM HEPES, 2 mM DTT, 1% Brij-35 (w/v), pH 7.0
  • Recombinant Human Vanin-1/VNN1 (rhVNN1) (Catalog # 7999-AH)
  • Substrate: Pantethine (Sigma, Catalog # P2125) 50 mM stock in deionized water
  • o-pthalaldehyde (Sigma, Catalog # P0657) 50 mg/mL (373 mM) stock in DMSO
  • 0.5 M Sodium Borate, pH 9.0
  • F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
  • Fluorescent Plate Reader (Model: Gemini EM by Molecular Devices) or equivalent
  1. Dilute rhVNN1 to 1 µg/mL in Assay Buffer.
  2. Dilute Substrate to 500 µM in Assay Buffer.
  3. Load 50 µL of dilute rhVNN1 to empty wells of a black well plate.
  4. Start reaction by adding 50 µL of dilute substrate to wells containing enzyme. Create Enzyme Controls by not adding substrate to the wells.
  5. Seal plate with a plate sealer and incubate at 37 °C for 30 minutes.
  6. Prepare Detection mixture containing 15 mM oPA in 0.5 M sodium borate, pH 9.0.
  7. Add 100 µL Detection mixture to all wells used. For Enzyme Controls, add dilute substrate after Detection Mixture is added.
  8. Mix well and incubate sealed plate at room temperature for 5 minutes.
  9. Read at excitation and emission wavelengths of 330 nm and 450 nm (top read), respectively, in endpoint mode.
  10. Calculate specific activity:

     Specific Activity (pmol/min/µg) =

Adjusted Fluorescence* (RFU) x Conversion Factor** (pmol/RFU)
Incubation time (min) x amount of enzyme (µg)

     *Adjusted for Enzyme Control
     **Derived using calibration standard Cysteamine Hydrochloride (Sigma, Catalog # M6500).

Per Well:
  • rhVNN1: 0.050 μg
  • Substrate: 125 µM

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes
Loading...